11 – 17 of 17
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- « previous
- 1
- 2
- next »
- 2021
-
Mark
Imiquimod shows anti-viral actions in human bronchial epithelium - implications for COVID-19 treatment
2021) European Respiratory Society (ERS) congress 2021(
- Contribution to conference › Poster
-
Mark
Imiquimod Boosts Interferon Response, and Decreases ACE2 and Pro-Inflammatory Response of Human Bronchial Epithelium in Asthma
(
- Contribution to journal › Article
- 2020
-
Mark
Human host defense peptide LL-37 facilitates double-stranded RNA pro-inflammatory signaling through up-regulation of TLR3 expression in vascular smooth muscle cells
(
- Contribution to journal › Article
-
Mark
Imiquimod: ett nytt potentiellt läkemedel för COVID19?
(
- Contribution to conference › Abstract
-
Mark
SARS-CoV-2 Spike protein binds to bacterial lipopolysaccharide and boosts proinflammatory activity
(
- Contribution to journal › Article
- 2018
-
Mark
Interferon-β deficiency at asthma exacerbation promotes MLKL mediated necroptosis
(
- Contribution to journal › Article
-
Mark
IL-1β mediates lung neutrophilia and IL-33 expression in a mouse model of viral-induced asthma exacerbation
(
- Contribution to journal › Article
- « previous
- 1
- 2
- next »